Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
BrightGene Bio-Medical Technology Co., Ltd.
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
BMI ≥ 28.0 kg/m2 or 24.0 ≤ BMI \< 28.0 kg/m2 with at least 1 weight-related comorbidity at screening visit;
Controlled by diet and exercise alone for at least 12 weeks prior to Screening with \<5.0% change in body weight and able to continue the original diet and exercise for weight control during the trial.
You may not be if
Previous diagnosis of type 1 or type 2 diabetes mellitus;
History of acute or chronic pancreatitis, or pancreatic injury;
History of thyroid C-cell carcinoma, MEN (multiple endocrine adenomatosis) 2A or 2B, or relevant family history;
Subjects with uncontrolled hypertension after treatment (systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥ 100 mmHg at screening) or untreated blood pressure meeting the above criteria at screening;
Concomitant thyroid dysfunction that cannot be controlled at a stable drug dose atscreening, or clinically significant abnormalities in thyroid function test results at screening that require initiation of therapy;
At Screening, abdominal ultrasound indicated calculus gallbladder and polyps, or presence of clinical symptoms of gallbladder disease at Screening;
